PDCD1 and urinary bladder cancer: In addition, with respect to tumors such as melanoma and bladder cancer, not only tumor cells, but also the number of infiltrating T cells and the proportion of T cells positive for PD-L1 or PD-1 expression, can be used as indices of therapeutic efficacy [27, 47, 71].